bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
HEXACHLOROPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
HEXACHLOROPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
HEXACHLOROPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
HEXACHLOROPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
HEXACHLOROPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
HEXACHLOROPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
PERHEXILINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
PERHEXILINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
PERHEXILINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
PERHEXILINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
PERHEXILINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
PERHEXILINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
SULOCTIDIL |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
SULOCTIDIL |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
SULOCTIDIL |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
SULOCTIDIL |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
SULOCTIDIL |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
SULOCTIDIL |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
ZINC CHLORIDE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
ZINC CHLORIDE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
CYPROTERONE ACETATE |
CYP450-3A4 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
CHLORMADINONE ACETATE |
CYP450-3A4 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
VALDECOXIB |
CYP450-3A4 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
EBASTINE |
CYP450-2D6 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
VALDECOXIB |
CYP450-2D6 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
17-METHYLTESTOSTERONE |
CYP450-3A4 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
DIPYRIDAMOLE |
CYP450-2D6 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
FELODIPINE |
CYP450-2D6 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
TOPOTECAN |
CYP450-2D6 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
FLUBENDAZOLE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
FLUBENDAZOLE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
BUTENAFINE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
BUTENAFINE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
EPALRESTAT |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
EPALRESTAT |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
IPRIFLAVONE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
IPRIFLAVONE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
TRANILAST |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
TRANILAST |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
PHENINDIONE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
PHENINDIONE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
PANTOPRAZOLE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
PANTOPRAZOLE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
QUETIAPINE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
FELBINAC |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
FELBINAC |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
FELBINAC |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
FELBINAC |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
FELBINAC |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
FELBINAC |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
FELBINAC |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
FELBINAC |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
TOLMETIN |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
TOPOTECAN |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
TOPOTECAN |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 1 (interstitial collagenase) |
MEBENDAZOLE |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
MECLOFENAMIC ACID |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
MECLOFENAMIC ACID |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
MECLOFENAMIC ACID |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
MECLOFENAMIC ACID |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
VINDESINE |
Adrenergic alpha2B |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
FLAVOXATE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
FLAVOXATE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
MEFENAMIC ACID |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
MEFENAMIC ACID |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
TOPOTECAN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
TOPOTECAN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
MEFENAMIC ACID |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
caspase 2 |
QUINOLONE, CHEMI-LINZ / CYANAMID |
Protease, Caspase 1 |
-20% |
NoneNone |
NoneNone |
View
|
caspase 7 |
QUINOLONE, CHEMI-LINZ / CYANAMID |
Protease, Caspase 1 |
-20% |
NoneNone |
NoneNone |
View
|
caspase 6 |
QUINOLONE, CHEMI-LINZ / CYANAMID |
Protease, Caspase 1 |
-20% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
SULINDAC SULFIDE |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
QUINOLONE, CHEMI-LINZ / CYANAMID |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
QUINOLONE, CHEMI-LINZ / CYANAMID |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
caspase 1 |
QUINOLONE, CHEMI-LINZ / CYANAMID |
Protease, Caspase 1 |
-20% |
NoneNone |
NoneNone |
View
|
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) |
QUINOLONE, CHEMI-LINZ / CYANAMID |
Protease, Caspase 1 |
-20% |
NoneNone |
NoneNone |
View
|
caspase 3, apoptosis related cysteine protease |
QUINOLONE, CHEMI-LINZ / CYANAMID |
Protease, Caspase 1 |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 2 |
MEGESTROL ACETATE |
Chemokine CCR2B |
-20% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, alpha polypeptide |
SULINDAC SULFIDE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, alpha polypeptide |
SULINDAC SULFIDE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, beta polypeptide |
SULINDAC SULFIDE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, beta polypeptide |
SULINDAC SULFIDE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
QUINOLONE, CHEMI-LINZ / CYANAMID |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
FLURBIPROFEN |
CYP450-2D6 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
MEGESTROL ACETATE |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 5a, mitochondrial |
L-MIMOSINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 3 |
L-MIMOSINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 2 |
L-MIMOSINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 4 |
L-MIMOSINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XI |
L-MIMOSINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase IX |
L-MIMOSINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
DIGITOXIN |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
DIGITOXIN |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
TAMOXIFEN |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
TAMOXIFEN |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
TAMOXIFEN |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
TAMOXIFEN |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
TAMOXIFEN |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
TAMOXIFEN |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
TAMOXIFEN |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
CLOFIBRATE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
CLOFIBRATE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
NIFEDIPINE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
NIFEDIPINE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
CLOFIBRATE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
CLOFIBRATE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
NIFEDIPINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
NIFEDIPINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
TRIAMCINOLONE ACETONIDE |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLOFIBRATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Phosphodiesterase PDE5 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Phosphodiesterase PDE5 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
HYDROCORTISONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
HYDROCORTISONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
DIGITOXIN |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
TAMOXIFEN |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
TAMOXIFEN |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
NIFEDIPINE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
NIFEDIPINE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
NIFEDIPINE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
HYDROCORTISONE |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
angiotensin II receptor, type 2 |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Angiotensin AT2 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Muscarinic M1 |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
CHLORPROMAZINE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
platelet-activating factor receptor |
TANNIC ACID |
Platelet Activating Factor (PAF) |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
TANNIC ACID |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 2 |
TANNIC ACID |
Chemokine CCR2B |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 2 |
U-78517F |
Chemokine CCR2B |
-20% |
NoneNone |
NoneNone |
View
|
endothelin receptor type A |
IBUPROFEN |
Endothelin ETA |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
CLOTRIMAZOLE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
CHLORPROMAZINE |
Calcitonin |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
CHLORPROMAZINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
CHLORPROMAZINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
CHLORPROMAZINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 5a, mitochondrial |
AMIODARONE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 3 |
AMIODARONE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 2 |
AMIODARONE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 4 |
AMIODARONE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XI |
AMIODARONE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase IX |
AMIODARONE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VIII |
AMIODARONE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VII |
AMIODARONE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VA, mitochondrial |
AMIODARONE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase IV |
AMIODARONE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase III, muscle specific |
AMIODARONE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|